Pipeline

Pipeline

Our product pipeline currently has four programs that have been developed using our proprietary technology. Three of which are approaching Clinical Candidate status, while the fourth is near the Lead Optimization stage.

Candidate & Indication Lead Identification Lead Optimization Clinical Candidate
NUC-404 HBV Nucleotide Analog plus LTP Technology Lead Identification Phase complete
Lead Optimization Phase in progress
Clinical Candidate Phase not started
NUC-202 Gemcitabine Analog plus LTP Technology Lead Identification Phase complete
Lead Optimization Phase in progress
Clinical Candidate Phase not started
NUC-101 HCV Nucleotide Analog plus LTP Technology Lead Identification Phase complete
Lead Optimization Phase in progress
Clinical Candidate Phase not started
NUC-303 Gemcitabine Analog Technology Lead Identification Phase in progress
Lead Optimization Phase not started
Clinical Candidate Phase not started